# Lyka Labs Ltd (LYKALABS)
> Exchange: NSE | Sector: Pharma | ISIN: INE933A01014

## About
Lyka Labs Ltd is a Pharma company listed on NSE.
Sector: Pharma

## Returns
1Y Return: 2.41%

## Valuation
P/E: —
P/B: 3.2
EPS: -₹2.5
Book Value: ₹25.9
Dividend Yield: 0%

## Profitability
ROE: -10.2%

## Access
Current tier: anonymous
More history: Register free to see 9 more years.

## Data Freshness
Quote Updated: 2026-09-07T08:44:17.000Z
Price History Updated: 2026-09-09T16:56:28.630Z
Latest Price History Date: 2026-09-07
Technicals Updated: 2026-09-09T16:56:28.630Z
Quant Updated: 2026-09-09T16:56:28.630Z
Sentiment Updated: 2026-09-09T16:56:28.630Z
Financials Status: current
Financials Updated: 2026-09-12T03:27:08.210Z
Financials Last Attempt: 2026-09-12T03:27:08.210Z
Financials Provider Tried: screener.in+yahoo
Latest P&L Period: FY26
Latest Balance Sheet Period: FY26
Latest Cash Flow Period: FY26

## P&L (TTM)
Revenue: ₹138 Cr
Operating Profit: ₹-3 Cr (OPM -2%)
Net Profit: ₹-9 Cr
Tax: ₹-2 Cr

## Annual P&L History
TTM: Rev ₹138Cr | PAT ₹-9Cr | OPM -2%
FY26: Rev ₹128Cr | PAT ₹-10Cr | OPM -2.7%
FY25: Rev ₹138Cr | PAT ₹8Cr | OPM 13%

## Balance Sheet (FY26)
Total Assets: ₹175 Cr
Total Liabilities: ₹175 Cr
Borrowings: ₹49 Cr
Cash: —

## Shareholding
Promoters: 58.45%
FIIs: 0.17%
DIIs: 0.66%
Public: 40.73%

---
Source: rupiya.io/stocks/lykalabs
Disclaimer: For research and education only. Not investment advice.